Josh Gottheimer: “I have an amendment at the desk. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is…”

“I have an amendment at the desk. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: At the end of subtitle B of title VII, insert the following: SEC. 712. STUDY ON HIGH-RISK, HIGH-REWARD DRUGS. (a) In General.--Not later than 180 days after the date of enactment of this Act, the Secretary of Health and Human Services shall conduct a study to identify-- (1) diseases or conditions that lack a treatment approved by the Food and Drug Administration and instances in which development of a treatment for such diseases or conditions could fill an unmet medical need for the treatment of a serious or life-threatening disease or condition or a rare disease or condition; and (2) appropriate incentives that would lead to the development, approval, and marketing of such treatments. (b) Report to Congress; Recommendations.--Not later than one year after the date of enactment of this Act, the Secretary shall submit to the Congress a report that includes-- (1) findings from the study under subsection (a); and (2) recommendations regarding legislation necessary to create appropriate incentives identified pursuant to subsection (a)(2). The Acting CHAIR. Pursuant to House Resolution 758, the gentleman from New Jersey (Mr. Gottheimer) and a Member opposed each will control 5 minutes. The Chair recognizes the gentleman from New Jersey.”